Background: White spot lesions (WSL) frequently occur as side-effect of multibracket appliance treatment. The clinical effects of local fluoridation on post-orthodontic WSL and oral health development are however inconclusive. Objective: In vivo monitoring of clinical WSL and oral health changes in response to weekly 1.25 per cent fluoride gel application after multibracket appliance treatment. Trial design: Randomized, single-centre, double-blind, parallel-group, placebo-controlled study. Participants: Patients with not less than 1 WSL (modified score 1 or 2) on not less than 1 upper front teeth after debonding. Interventions: Professional fluoride/placebo gel application during weeks 1-2; self-administered home application (weeks 3-24). Outcomes: Clinical evaluation of WSL index, lesion activity, plaque index, gingival bleeding index, and decayed, missing, and filled teeth index as well as saliva buffer capacity and stimulated salivary flow rate (T0-T5). Randomization: Random assignment to test (n = 23) or placebo group (n = 23) using a sequentially numbered list (random allocation sequence generated for 50 subjects in 25 blocks of 2 subjects each). Recruitment: The clinical study duration lasted from March 2011 to September 2013. Blinding: Unblinding was performed after complete data evaluation. Numbers analysed: Intention-to-treat analysis set comprised 39 participants (test: n = 21, placebo: n = 18). Outcome: No clinical parameter except stimulated salivary flow rate (fluoride group: 1.1 ml/min, placebo group: 0.74 ml/min; P = 0.022) showed a statistically significant group difference after 24 weeks. Harms: Several adverse events occurred similarly frequent in both groups; none was classified as possibly related to the study product. Limitations: The number of dropouts was higher than expected and the socio-economic status was not assessed. Furthermore, the unknown level of compliance during the home application phase must be considered as limitation.
Introduction
White spot lesions (WSLs) are an undesired, though frequent side-effect of orthodontic fixed appliance treatment (Tx), with an incidence on upper front teeth (UFT) of up to 41 per cent of multibracket appliance (MBA) patients (1) . Lateral incisors were found to be at even higher risk than central incisors (2) .
Normally WSLs cease to develop when the MBA with its concomitant cariogenic challenge has been removed (3) . New WSL may recede and become less prominent (3) (4) (5) . Nevertheless, the lesions usually remain visible to varying extents and represent an aesthetic concern.
As fluoride products are known to reduce the risk of WSL development when applied orally (6) (7) (8) (9) (10) , some studies on fluoride use on WSLs to achieve remineralization have been performed (11) (12) (13) . However, evidence is still needed regarding the fluoride concentration, the application mode, and the influence on clinical parameters.
While a photographic data assessment was performed in Part I of this investigation (14) , the present Part II focuses on the clinical parameters.
Objective
To evaluate the clinical effects of an intra-oral high concentration (1.25 per cent) fluoride application on the development of WSLs after orthodontic MBA Tx. Null hypothesis (H0): no difference between high-dose fluoride gel and placebo.
Trial design
Single-centre prospective randomized placebo-controlled doubleblind clinical trial.
Subjects and methods

Registration
The study was registered with ClinicalTrials.gov (Identifier: NCT01329731).
Patient screening
Forty-six MBA patients (11 years and older) from the Department for Orthodontics, University of Giessen, Germany, who had received Tx including the upper jaw for at least 1 year) and exhibited not less than 1 WSL [modified score 1 or 2 (15)] on not less than 1 of the four upper front teeth (UFT) after debonding, were screened.
Randomization
The subjects were randomly assigned to either a test group (highdose fluoride gel) or a placebo group.
Treatment protocol and process
Overall, six visits were scheduled (Table 1 ) and the clinical duration of the study lasted from March 2011 (first recruitment) to September 2013 (completion).
At baseline and at the two following visits (T0 to T2), the operators applied the gel. After the third appointment (T2), the participants were instructed to apply the gel by themselves at home. The participants received written instructions on gel application as well as oral hygiene. Colgate-Palmolive Europe provided the necessary amount of study products, toothbrushes, amine fluoride-containing toothpaste, and stopwatches.
The detailed description of ethical issue, inclusion and exclusion criteria, study products used, and mode of application, as well as sample size calculation, has been fully described in Part I of this investigation (14) .
Study parameters
The current paper (Part II) presents the assessment of the following clinical study parameters (a detailed chart showing when the measures were undertaken is given in Table 1): -Modified WSL index (15) : the teeth 12-22 were dried with compressed air for 10 seconds, and the labial surface was visually examined using the scores 0 = no white spot formation; 1 = slight white spot formation, thin rim; 2 = excessive white spot formation, thicker bands; and 3 = white spot formation with cavitation. -Lesion activity assessment (LAA) according to the International Caries Detection and Assessment System (ICDAS II) (16) : the decision between active and inactive caries was made after air-drying each tooth surface (teeth 12-22) for 5 seconds using a standard dental probe; active lesion: surface of enamel is whitish/yellowish opaque with loss of luster and feels rough when the tip of the probe is moved gently across the surface; inactive lesion: surface of enamel is whitish, brownish, or black and may be shiny and hard or smooth when the tip of the probe is moved gently across the surface. -Plaque index (17) : the grades were assessed visually on teeth 12-22 using a standard dental probe: 0 = no plaque on inspection and probing; 1 = thin plaque film on gingival margin, detectable only on probing; 2 = moderate plaque film along the gingival margin, visually detectable even without probing; and 3 = much plaque along the gingival margin, filling the interdental spaces. -Gingival bleeding index (18) : The gingiva of teeth 12-22 was air-dried for 10 seconds, and a blunt periodontal probe PCP11 with a diameter of 0.5 mm was inserted into the gingival crevice with slight pressure and parallel to the long axis of the tooth, thereafter the probe was moved along the crevice. The following scores were used: 0 = no bleeding and 1 = bleeding occurred. -DMFT index (19) : Dental health of all teeth was assessed with respect to decay (D), missing (M), or filling (F). The DMFT index was calculated. -Stimulated salivary flow rate: Patients were instructed to swallow the saliva accumulated in their mouth. Thereafter, they were instructed to chew on a paraffin block (CRT buffer, Ivoclar Vivadent, Schaan, Liechtenstein) in their usual manner and to spit the stimulated saliva into a pre-tagged and pre-weighed sterile graduated container every minute. After 5 minutes, the collected volume of saliva was measured (ml/min). -Saliva buffer capacity: This parameter was assessed by means of a commercially available test (CRT buffer, Ivoclar Vivadent, Schaan, Liechtenstein).
Statistical analysis
The following analyses were conducted:
-Descriptive statistics (mean, median, standard deviation, minimum, and maximum) were calculated separately for each group at all appointments for which measurements were done. -Wilcoxon-Mann-Whitney U-test to compare the difference between the two groups for all parameters with the exception of the binary variables gingival bleeding index and caries activity index at all available appointments. -Two-sample binomial test for the binary variables gingival bleeding index and caries activity index at all available appointments to compare the two Tx groups.
The significance level was set to α = 0.05. There was no adjustment for multiplicity of tests. The following results are based on an intention-to-treat analysis.
Results
Patient flow
A flow chart showing the course of the trial is given in Part I of this study (14) .
Baseline data
The two groups were comparable with respect to age, gender, and other baseline characteristics ( Table 2) .
Study outcomes
The results on the clinical effects of the topical high-dose fluoride application on WSL development are given below as well as in Supplementary Tables 1-7 Looking at all WSLs categorized as "grade 1" at T0, improvement to "grade 0" was seen in 24 per cent (test group) and 35 per cent (placebo group) of these WSLs. No change was detected in 76 per cent (test group) and 62 per cent (placebo group) of the WSLs. Deterioration occurred in the placebo group only. For the WSLs categorized as "grade 2" at T0, improvement occurred in 81 per cent (test group) and 65 per cent (placebo group) of these WSLs, while the remaining WSLs exhibited no change.
-LAA according to the ICDAS II [(16); detailed data given in Supplementary Table 2 ]: At T0, more active lesions were seen in the placebo group compared with the test group. However, both groups exhibited less active than inactive lesions. At both T4 and T5, the test group showed less active lesions on teeth 12, 11, and 21 compared with the placebo group; for tooth 22, less active lesions were seen in the test group compared with the placebo group at T4, while the situation was vice versa at T5. One WSL had progressed into cavitation which had to receive conservative Tx. Nevertheless, no significant group difference was seen at any time point. -Plaque index [(17) ; detailed data given in Supplementary Table 4 ]: Bleeding on probing was slightly less frequent in the test group compared with the placebo group at T0; at T4 and T5, the situation was vice versa. However, no statistically significant group difference was seen at any time point. 
a Including therapies/treatments within 30 days prior to enrolment. -DMFT index [(19) ; detailed data given in Supplementary -Stimulated salivary flow rate (detailed data given in Supplementary Table 6 ): The mean flow rate ranged between 1.05 and 1.19 ml/min in the test group and 0.74 and 0.84 ml/min in the placebo group. While no statistically significant group difference was found at T0, this was different at T4 (P = 0.012) and T5 (P = 0.022). -Saliva buffer capacity (detailed data given in Supplementary 36.9 per cent in the placebo group, respectively. Nevertheless, no significant difference was seen between the two groups. However, the results revealed that the method used for the assessment of WSL dimension would benefit from refinement and validation. Therefore, it was of major interest to assess whether these findings would be substantiated by the clinical parameters or not. A discussion of subjects and photographic methods can be found in Part I of the study (14) .
Part II of the trial
Regarding the results of the clinical WSL evaluation, both variables used-modified WSL index (15) and caries activity index (LAA) according to ICDAS II (16)-can be considered as standard procedures in caries lesion assessment and have been used in a substantial number of previous studies before (1, 8, (20) (21) (22) (23) (24) (25) (26) . The modified WSL index (15) assesses the horizontal extent of the WSL semi-quantitatively based on a four-degree scale, which results in a certain inaccuracy but is realistic in terms of clinical assessment. The caries activity index (LAA) has been demonstrated to be reproducible, valid, and accurate (16, 27, 28) .
The plaque index according to Silness and Löe (17) was chosen, as it does evaluate both the presence and the quantity of plaque. As a second indicator on oral health, the gingival bleeding index was used. In comparison with plaque as a major cause for gingivitis, inflammation originating from the periodontal sulcus is less prone to short-term variations (29) .
As it is known that saliva is a major factor influencing demineralization and remineralization and thus the development of carious lesions (30) (31) (32) (33) , the flow rate and buffer capacity were measured.
Only few randomized clinical trials evaluating WSL development after MBA Tx exist. While some of these studies assessed the application of fluoride (12, 34, 35) , others investigated the use of casein phosphopeptide amorphous calcium phosphate for remineralization (36) (37) (38) (39) . However, no study has evaluated the application of a fluoride product with a similar fluoride content as in the current product (1.25 per cent) so far. One study (12) however investigated a product with even higher fluoride contents (5 per cent). The study duration was similar as in the present investigation, but due to professional use only, a more reliable application (which was performed over a 4-week interval) compared with the present study might be expected. Quantitative light-induced fluorescence (QLF) was used to assess the WSL changes and a significantly higher reduction was found in the test group (DIAGNOdent pen scores: test = 7.56 versus control = 3.09). However, the clinical relevance of these values remains unclear. QLF was the only method used to evaluate the WSLs, and due to the problems associated with QLF [inconsistent handling by the investigator, remaining surface moisture, presence of plaque, or tartar (40, 41) ], the results must be interpreted with care. Nevertheless, a hint regarding the effectiveness of fluoride varnish may be derived.
The modified WSL index according to Gorelick et al. (15) revealed that upper lateral incisors had a higher risk for WSL development than upper central incisors. This is in concordance with the data in the literature (2, 8, 15, 22, 25, 42) , and the results on both WSL dimension and WSL luminance are described in Part I of the present study (14) .
Most studies report a symmetric WSL distribution on the right and left sides of the dentition (2, 15, 42) ; in the present study, this was only true for lateral incisors, while the central incisors were more often affected on the right side. The reason for the asymmetric pattern in the present study might be right-handed brushing in the majority of the patients. However, comparing these findings with the results of Part I of the present investigation (14) , no asymmetric effect was apparent among the WSL dimension and WSL luminance data.
Looking at WSL development, slightly more "grade 1" lesions improved in the placebo group (35 per cent) than in the test group (24 per cent). For more severe "grade 2" lesions, however, a more favourable development was seen in the test group (81 per cent improved) compared with the placebo group (65 per cent improved). Deterioration was only seen in the placebo group. These data suggest that more severe/ larger lesions are more prone to improvement irrespective of fluoride Tx, whereas less severe/smaller lesions tend to remain constant. While this result seems to be in contrast to the findings of other studies (11, 43) , one has to keep in mind that the WSL index (15) is mainly based on lesion size that does not necessarily correlate with lesion depth.
In concordance with the literature (44), more WSL were inactive than active according to ICDAS II at baseline in both groups of the present study. Inactive lesions have been shown to be more resistant against acid attacks than healthy enamel (45, 46) . During the course of the present study, the number of inactive lesions further increased as it had also been observed by Bailey et al. (37) . The observation made by Øgaard et al. (47) and Øgaard and ten Bosch (48) that remineralization might be initiated even by saliva itself (without additional fluoride contents) might explain why the number of active WSL deteriorated in both groups of the present study as it was seen for WSL dimension and WSL luminance in Part I of the study (14) .
More than half of the participants exhibited at least some plaque accumulation (plaque index grade greater than 0) at baseline. This corresponds to the fact that WSL development is-at least to a certain extent-related to the presence of plaque. However, the most common plaque index grade in the test group was 1, while it was 2 in the placebo group. As the baseline value was determined with the MBA being still in place, a distinct reduction could be seen and was to be expected at the follow-up appointments when it was less effort for the patients to perform a sound oral hygiene. A similar effect was observed by Årtun and Thylstrup (49) . On the other hand, the Hawthorne effect might also have evoked some of the reduction in the present study as the patients were aware of being part of a trial. This kind of effect has been observed before (50, 51) . Nevertheless, the plaque index values never approached grade 0 in the study population of the present investigation.
As already mentioned for the plaque index, the oral hygiene at baseline was somewhat poorer in the placebo group; as a consequence, bleeding on probing was more frequent as well. During the whole observation period, the amount of bleeding events varied between 19 and 57 per cent in the test and 11 and 56 per cent in the placebo group. So, the group difference was not significant and both groups seem to have performed oral hygiene on a similar level.
While 62 per cent of the test group and 50 per cent of the placebo group exhibited a DMFT index value of 0 at baseline, the mean value of all patients was 1.26 and therefore higher than corresponding regional population reference data of 1.14 (52). In both groups, the DMFT index increased during the observation period. At the end of the study, only 42 per cent of the test and 33 per cent of the placebo group exhibited a value of 0. Also these values are less favourable than the corresponding regional population reference data of 61.5 per cent (52) . The mean DMFT value increased to 2.05 at the end of the study, which is quite surprising as the removal of the MBA should have made oral hygiene much easier for the patients. However, some lesions (not necessarily on upper front teeth) might have deteriorated, and this would be in concordance with our clinical experience where especially WSL on lower premolars and canines sometimes exhibit deterioration with cavitation. Nevertheless, the DMFT data are comparable to the literature in terms of respective values after orthodontic Tx. Splieth et al. (7) reported mean values of 2.36-2.96 after 2 years of MBA Tx (baseline values 1.60-2.00). However, for the present investigation, no statistically significant group difference was found for any of these variables.
The saliva flow rate was about 1/4 higher in the test group. While no statistically significant group difference existed, the values seen during this study are generally quite low compared with those in the literature [(33); test group nearly 1.1 ml/min and placebo group nearly 0.7 ml/min vs. 1-3 ml/min]. While values below 0.7 ml/min are considered as very low and prone for a high risk for caries, some of the patients in both groups of the present study showed values of only 0.2 ml/min. So, this could explain WSL development in the study population to a certain extent.
The saliva buffer capacity is in close relation to saliva flow rate (53) . Therefore, the patients in the placebo group had a lower buffer capacity. There are, however, no data in the literature available regarding the changes of both saliva flow rate and buffer capacity during MBA Tx. Nevertheless, orthodontic patients have been shown to have a significantly higher saliva flow rate compared with the untreated controls (54, 55) , with the flow rate being a major factor in caries prevention (33) supporting the natural cleaning process, increasing the buffer capacity and the antibacterial activity.
Limitations
Several limitations have to be considered when evaluating the results of the present randomized controlled trial. First of all, the number of dropouts was much higher than expected. However, due to randomization both the test and the placebo groups were affected. Another limitation regarding the study population is the socio-economic status, which was not assessed. But again, due to randomization, the respective structure should be similar in both groups.
Another limitation certainly is the compliance. Due to practicability reasons, it was impossible to assess whether the participants followed the instructions on oral hygiene and fluoride/study product application during the second (home use) phase. While efforts were made to control this uncertainty (questionnaire and assessment of tube weight upon each visit), compliance must be considered as a possible confounding factor.
Generalization
The results of the present study can be generalized for patient groups with a similar mean age (~15 years), inclusion/exclusion criteria (especially with respect to the initial WSL with a modified score 1 or 2 (15)) and treatment protocol (especially in terms of the study products' fluoride concentration).
However, as the present investigation did not result in conclusive evidence regarding the Tx of WSL which developed during orthodontic MBA Tx, several open questions remain and the data clearly indicate a further need for improvement and validation of the methods for monitoring WSLs in clinical trials.
Conclusion
Investigating the clinical parameters modified WSL index, caries activity index, plaque index, gingival bleeding index, DMFT index, saliva buffer capacity and stimulated salivary flow rate, no significant positive effect of high-dose fluoride (1.25 percent) Tx on clinical post-orthodontic WSL development was seen when compared with the placebo Tx. However, as the trial statistic was designed to show superiority of high-dose fluoride Tx, nonsignificant intergroup findings do not prove that treatment groups are equivalent.
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